nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.0358	0.361	CbGeAlD
Propericiazine—Atrial arrhythmia—Galantamine—Alzheimer's disease	0.0329	0.0428	CcSEcCtD
Propericiazine—Cardiac fibrillation—Rivastigmine—Alzheimer's disease	0.0241	0.0313	CcSEcCtD
Propericiazine—Arrhythmia supraventricular—Galantamine—Alzheimer's disease	0.0235	0.0306	CcSEcCtD
Propericiazine—Atrial arrhythmia—Memantine—Alzheimer's disease	0.0231	0.0301	CcSEcCtD
Propericiazine—Tardive dyskinesia—Memantine—Alzheimer's disease	0.0172	0.0224	CcSEcCtD
Propericiazine—Dental caries—Memantine—Alzheimer's disease	0.0172	0.0224	CcSEcCtD
Propericiazine—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.0169	0.0219	CcSEcCtD
Propericiazine—Dental caries—Rivastigmine—Alzheimer's disease	0.0169	0.0219	CcSEcCtD
Propericiazine—Arrhythmia supraventricular—Memantine—Alzheimer's disease	0.0166	0.0216	CcSEcCtD
Propericiazine—Parkinsonism—Memantine—Alzheimer's disease	0.0141	0.0184	CcSEcCtD
Propericiazine—Altered state of consciousness—Memantine—Alzheimer's disease	0.0139	0.0181	CcSEcCtD
Propericiazine—Parkinsonism—Rivastigmine—Alzheimer's disease	0.0138	0.018	CcSEcCtD
Propericiazine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.0138	0.018	CcSEcCtD
Propericiazine—Embolism venous—Memantine—Alzheimer's disease	0.0127	0.0166	CcSEcCtD
Propericiazine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.0125	0.0163	CcSEcCtD
Propericiazine—Sudden death—Memantine—Alzheimer's disease	0.0125	0.0163	CcSEcCtD
Propericiazine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.0123	0.016	CcSEcCtD
Propericiazine—Deep vein thrombosis—Donepezil—Alzheimer's disease	0.0116	0.0151	CcSEcCtD
Propericiazine—Deep vein thrombosis—Memantine—Alzheimer's disease	0.0106	0.0137	CcSEcCtD
Propericiazine—Aggression—Galantamine—Alzheimer's disease	0.0104	0.0135	CcSEcCtD
Propericiazine—Atrioventricular block—Galantamine—Alzheimer's disease	0.00941	0.0122	CcSEcCtD
Propericiazine—Glaucoma—Donepezil—Alzheimer's disease	0.00939	0.0122	CcSEcCtD
Propericiazine—DRD1—forebrain—Alzheimer's disease	0.00935	0.0942	CbGeAlD
Propericiazine—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00912	0.0119	CcSEcCtD
Propericiazine—DRD1—telencephalon—Alzheimer's disease	0.0086	0.0867	CbGeAlD
Propericiazine—Glaucoma—Memantine—Alzheimer's disease	0.00853	0.0111	CcSEcCtD
Propericiazine—Glaucoma—Rivastigmine—Alzheimer's disease	0.00834	0.0109	CcSEcCtD
Propericiazine—Aggression—Donepezil—Alzheimer's disease	0.00805	0.0105	CcSEcCtD
Propericiazine—Aggression—Memantine—Alzheimer's disease	0.00731	0.00951	CcSEcCtD
Propericiazine—Atrioventricular block—Donepezil—Alzheimer's disease	0.00729	0.00949	CcSEcCtD
Propericiazine—Aggression—Rivastigmine—Alzheimer's disease	0.00715	0.00931	CcSEcCtD
Propericiazine—Dyskinesia—Memantine—Alzheimer's disease	0.00683	0.00889	CcSEcCtD
Propericiazine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00668	0.0087	CcSEcCtD
Propericiazine—Atrioventricular block—Memantine—Alzheimer's disease	0.00662	0.00862	CcSEcCtD
Propericiazine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00647	0.00843	CcSEcCtD
Propericiazine—Pulmonary embolism—Memantine—Alzheimer's disease	0.00642	0.00836	CcSEcCtD
Propericiazine—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00628	0.00818	CcSEcCtD
Propericiazine—Hypokalaemia—Galantamine—Alzheimer's disease	0.00603	0.00785	CcSEcCtD
Propericiazine—Increased appetite—Donepezil—Alzheimer's disease	0.00546	0.00711	CcSEcCtD
Propericiazine—ADRA1B—nervous system—Alzheimer's disease	0.00545	0.0549	CbGeAlD
Propericiazine—ADRA1B—central nervous system—Alzheimer's disease	0.00524	0.0528	CbGeAlD
Propericiazine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00516	0.00672	CcSEcCtD
Propericiazine—Pneumonia—Galantamine—Alzheimer's disease	0.00513	0.00668	CcSEcCtD
Propericiazine—DRD1—nervous system—Alzheimer's disease	0.00508	0.0512	CbGeAlD
Propericiazine—Increased appetite—Memantine—Alzheimer's disease	0.00496	0.00646	CcSEcCtD
Propericiazine—DRD1—central nervous system—Alzheimer's disease	0.00489	0.0493	CbGeAlD
Propericiazine—Increased appetite—Rivastigmine—Alzheimer's disease	0.00485	0.00632	CcSEcCtD
Propericiazine—Hypokalaemia—Donepezil—Alzheimer's disease	0.00467	0.00608	CcSEcCtD
Propericiazine—Asthma—Donepezil—Alzheimer's disease	0.00444	0.00577	CcSEcCtD
Propericiazine—Eosinophilia—Donepezil—Alzheimer's disease	0.00439	0.00572	CcSEcCtD
Propericiazine—Sweating increased—Donepezil—Alzheimer's disease	0.00432	0.00563	CcSEcCtD
Propericiazine—ADRA2A—forebrain—Alzheimer's disease	0.00429	0.0432	CbGeAlD
Propericiazine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00425	0.00554	CcSEcCtD
Propericiazine—Hypokalaemia—Memantine—Alzheimer's disease	0.00424	0.00552	CcSEcCtD
Propericiazine—ADRA1B—brain—Alzheimer's disease	0.00416	0.042	CbGeAlD
Propericiazine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00415	0.0054	CcSEcCtD
Propericiazine—Arrhythmia—Galantamine—Alzheimer's disease	0.00409	0.00533	CcSEcCtD
Propericiazine—Weight increased—Donepezil—Alzheimer's disease	0.00404	0.00526	CcSEcCtD
Propericiazine—Asthma—Memantine—Alzheimer's disease	0.00403	0.00524	CcSEcCtD
Propericiazine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.004	0.00521	CcSEcCtD
Propericiazine—Pneumonia—Donepezil—Alzheimer's disease	0.00398	0.00518	CcSEcCtD
Propericiazine—ADRA2A—telencephalon—Alzheimer's disease	0.00394	0.0397	CbGeAlD
Propericiazine—Sweating increased—Memantine—Alzheimer's disease	0.00392	0.00511	CcSEcCtD
Propericiazine—DRD1—brain—Alzheimer's disease	0.00388	0.0391	CbGeAlD
Propericiazine—Jaundice—Donepezil—Alzheimer's disease	0.00386	0.00502	CcSEcCtD
Propericiazine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00384	0.005	CcSEcCtD
Propericiazine—Vision blurred—Galantamine—Alzheimer's disease	0.00376	0.00489	CcSEcCtD
Propericiazine—Tremor—Galantamine—Alzheimer's disease	0.00374	0.00486	CcSEcCtD
Propericiazine—Erectile dysfunction—Memantine—Alzheimer's disease	0.00371	0.00483	CcSEcCtD
Propericiazine—Weight increased—Memantine—Alzheimer's disease	0.00367	0.00477	CcSEcCtD
Propericiazine—Agitation—Galantamine—Alzheimer's disease	0.00367	0.00477	CcSEcCtD
Propericiazine—Hyperglycaemia—Memantine—Alzheimer's disease	0.00363	0.00473	CcSEcCtD
Propericiazine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00363	0.00472	CcSEcCtD
Propericiazine—Pneumonia—Memantine—Alzheimer's disease	0.00361	0.0047	CcSEcCtD
Propericiazine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.0036	0.00468	CcSEcCtD
Propericiazine—Weight increased—Rivastigmine—Alzheimer's disease	0.00359	0.00467	CcSEcCtD
Propericiazine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00355	0.00463	CcSEcCtD
Propericiazine—Pneumonia—Rivastigmine—Alzheimer's disease	0.00353	0.0046	CcSEcCtD
Propericiazine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00351	0.00457	CcSEcCtD
Propericiazine—Agranulocytosis—Memantine—Alzheimer's disease	0.00335	0.00436	CcSEcCtD
Propericiazine—Dry mouth—Galantamine—Alzheimer's disease	0.00332	0.00432	CcSEcCtD
Propericiazine—Confusional state—Galantamine—Alzheimer's disease	0.00328	0.00427	CcSEcCtD
Propericiazine—Tachycardia—Galantamine—Alzheimer's disease	0.00318	0.00414	CcSEcCtD
Propericiazine—Arrhythmia—Donepezil—Alzheimer's disease	0.00317	0.00413	CcSEcCtD
Propericiazine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00315	0.0041	CcSEcCtD
Propericiazine—Hypotension—Galantamine—Alzheimer's disease	0.00304	0.00396	CcSEcCtD
Propericiazine—Cardiac disorder—Memantine—Alzheimer's disease	0.00299	0.0039	CcSEcCtD
Propericiazine—Insomnia—Galantamine—Alzheimer's disease	0.00294	0.00383	CcSEcCtD
Propericiazine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00293	0.00381	CcSEcCtD
Propericiazine—Vision blurred—Donepezil—Alzheimer's disease	0.00291	0.00379	CcSEcCtD
Propericiazine—Tremor—Donepezil—Alzheimer's disease	0.0029	0.00377	CcSEcCtD
Propericiazine—Somnolence—Galantamine—Alzheimer's disease	0.00289	0.00377	CcSEcCtD
Propericiazine—Arrhythmia—Memantine—Alzheimer's disease	0.00288	0.00375	CcSEcCtD
Propericiazine—Agitation—Donepezil—Alzheimer's disease	0.00284	0.0037	CcSEcCtD
Propericiazine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00282	0.00367	CcSEcCtD
Propericiazine—Constipation—Galantamine—Alzheimer's disease	0.00278	0.00362	CcSEcCtD
Propericiazine—Vision blurred—Memantine—Alzheimer's disease	0.00264	0.00344	CcSEcCtD
Propericiazine—Tremor—Memantine—Alzheimer's disease	0.00263	0.00342	CcSEcCtD
Propericiazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00259	0.00337	CcSEcCtD
Propericiazine—Agitation—Memantine—Alzheimer's disease	0.00258	0.00336	CcSEcCtD
Propericiazine—Dry mouth—Donepezil—Alzheimer's disease	0.00257	0.00335	CcSEcCtD
Propericiazine—Body temperature increased—Galantamine—Alzheimer's disease	0.00257	0.00335	CcSEcCtD
Propericiazine—Tremor—Rivastigmine—Alzheimer's disease	0.00257	0.00335	CcSEcCtD
Propericiazine—Confusional state—Donepezil—Alzheimer's disease	0.00254	0.00331	CcSEcCtD
Propericiazine—Agitation—Rivastigmine—Alzheimer's disease	0.00252	0.00328	CcSEcCtD
Propericiazine—Oedema—Donepezil—Alzheimer's disease	0.00252	0.00328	CcSEcCtD
Propericiazine—Infection—Donepezil—Alzheimer's disease	0.00251	0.00326	CcSEcCtD
Propericiazine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00244	0.00317	CcSEcCtD
Propericiazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.0024	0.00312	CcSEcCtD
Propericiazine—Hypotension—Donepezil—Alzheimer's disease	0.00236	0.00307	CcSEcCtD
Propericiazine—Dry mouth—Memantine—Alzheimer's disease	0.00234	0.00304	CcSEcCtD
Propericiazine—ADRA2A—nervous system—Alzheimer's disease	0.00233	0.0234	CbGeAlD
Propericiazine—Confusional state—Memantine—Alzheimer's disease	0.00231	0.00301	CcSEcCtD
Propericiazine—Oedema—Memantine—Alzheimer's disease	0.00229	0.00298	CcSEcCtD
Propericiazine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00229	0.00298	CcSEcCtD
Propericiazine—Insomnia—Donepezil—Alzheimer's disease	0.00228	0.00297	CcSEcCtD
Propericiazine—Infection—Memantine—Alzheimer's disease	0.00228	0.00296	CcSEcCtD
Propericiazine—Confusional state—Rivastigmine—Alzheimer's disease	0.00226	0.00294	CcSEcCtD
Propericiazine—Dyspnoea—Donepezil—Alzheimer's disease	0.00225	0.00293	CcSEcCtD
Propericiazine—Somnolence—Donepezil—Alzheimer's disease	0.00224	0.00292	CcSEcCtD
Propericiazine—Oedema—Rivastigmine—Alzheimer's disease	0.00224	0.00292	CcSEcCtD
Propericiazine—ADRA2A—central nervous system—Alzheimer's disease	0.00224	0.0226	CbGeAlD
Propericiazine—Tachycardia—Memantine—Alzheimer's disease	0.00224	0.00291	CcSEcCtD
Propericiazine—Diarrhoea—Galantamine—Alzheimer's disease	0.00223	0.0029	CcSEcCtD
Propericiazine—Infection—Rivastigmine—Alzheimer's disease	0.00223	0.0029	CcSEcCtD
Propericiazine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00221	0.00288	CcSEcCtD
Propericiazine—ADRA2A—cerebellum—Alzheimer's disease	0.00219	0.0221	CbGeAlD
Propericiazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00219	0.00285	CcSEcCtD
Propericiazine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00217	0.00282	CcSEcCtD
Propericiazine—Constipation—Donepezil—Alzheimer's disease	0.00216	0.00281	CcSEcCtD
Propericiazine—Hypotension—Memantine—Alzheimer's disease	0.00214	0.00279	CcSEcCtD
Propericiazine—Hypotension—Rivastigmine—Alzheimer's disease	0.00209	0.00273	CcSEcCtD
Propericiazine—Insomnia—Memantine—Alzheimer's disease	0.00207	0.0027	CcSEcCtD
Propericiazine—Vomiting—Galantamine—Alzheimer's disease	0.00207	0.00269	CcSEcCtD
Propericiazine—Rash—Galantamine—Alzheimer's disease	0.00205	0.00267	CcSEcCtD
Propericiazine—Dermatitis—Galantamine—Alzheimer's disease	0.00205	0.00267	CcSEcCtD
Propericiazine—Dyspnoea—Memantine—Alzheimer's disease	0.00204	0.00266	CcSEcCtD
Propericiazine—Somnolence—Memantine—Alzheimer's disease	0.00204	0.00265	CcSEcCtD
Propericiazine—Insomnia—Rivastigmine—Alzheimer's disease	0.00203	0.00264	CcSEcCtD
Propericiazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.002	0.0026	CcSEcCtD
Propericiazine—Body temperature increased—Donepezil—Alzheimer's disease	0.00199	0.0026	CcSEcCtD
Propericiazine—Somnolence—Rivastigmine—Alzheimer's disease	0.00199	0.00259	CcSEcCtD
Propericiazine—Constipation—Memantine—Alzheimer's disease	0.00196	0.00255	CcSEcCtD
Propericiazine—Nausea—Galantamine—Alzheimer's disease	0.00193	0.00252	CcSEcCtD
Propericiazine—Constipation—Rivastigmine—Alzheimer's disease	0.00192	0.00249	CcSEcCtD
Propericiazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00186	0.00242	CcSEcCtD
Propericiazine—Body temperature increased—Memantine—Alzheimer's disease	0.00181	0.00236	CcSEcCtD
Propericiazine—ADRA2A—brain—Alzheimer's disease	0.00178	0.0179	CbGeAlD
Propericiazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00177	0.00231	CcSEcCtD
Propericiazine—Diarrhoea—Donepezil—Alzheimer's disease	0.00173	0.00225	CcSEcCtD
Propericiazine—Hypersensitivity—Memantine—Alzheimer's disease	0.00169	0.0022	CcSEcCtD
Propericiazine—Zuclopenthixol—HTR6—Alzheimer's disease	0.00168	0.0526	CrCbGaD
Propericiazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00165	0.00215	CcSEcCtD
Propericiazine—Vomiting—Donepezil—Alzheimer's disease	0.0016	0.00209	CcSEcCtD
Propericiazine—Rash—Donepezil—Alzheimer's disease	0.00159	0.00207	CcSEcCtD
Propericiazine—Dermatitis—Donepezil—Alzheimer's disease	0.00159	0.00207	CcSEcCtD
Propericiazine—Diarrhoea—Memantine—Alzheimer's disease	0.00157	0.00204	CcSEcCtD
Propericiazine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00153	0.002	CcSEcCtD
Propericiazine—Nausea—Donepezil—Alzheimer's disease	0.0015	0.00195	CcSEcCtD
Propericiazine—Vomiting—Memantine—Alzheimer's disease	0.00146	0.0019	CcSEcCtD
Propericiazine—Thiothixene—HTR6—Alzheimer's disease	0.00145	0.0454	CrCbGaD
Propericiazine—Rash—Memantine—Alzheimer's disease	0.00144	0.00188	CcSEcCtD
Propericiazine—Dermatitis—Memantine—Alzheimer's disease	0.00144	0.00188	CcSEcCtD
Propericiazine—Mesoridazine—HTR6—Alzheimer's disease	0.00143	0.0448	CrCbGaD
Propericiazine—Vomiting—Rivastigmine—Alzheimer's disease	0.00142	0.00185	CcSEcCtD
Propericiazine—Rash—Rivastigmine—Alzheimer's disease	0.00141	0.00184	CcSEcCtD
Propericiazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00141	0.00184	CcSEcCtD
Propericiazine—Fluphenazine—CALM1—Alzheimer's disease	0.00139	0.0435	CrCbGaD
Propericiazine—Nausea—Memantine—Alzheimer's disease	0.00136	0.00177	CcSEcCtD
Propericiazine—Nausea—Rivastigmine—Alzheimer's disease	0.00133	0.00173	CcSEcCtD
Propericiazine—Fluphenazine—HTR6—Alzheimer's disease	0.00125	0.0392	CrCbGaD
Propericiazine—Clomipramine—HTR6—Alzheimer's disease	0.00115	0.0359	CrCbGaD
Propericiazine—Promethazine—CALM1—Alzheimer's disease	0.00112	0.0352	CrCbGaD
Propericiazine—Trifluoperazine—CALM1—Alzheimer's disease	0.00111	0.0347	CrCbGaD
Propericiazine—Perphenazine—CALM1—Alzheimer's disease	0.0011	0.0344	CrCbGaD
Propericiazine—Thioridazine—HTR6—Alzheimer's disease	0.00108	0.0338	CrCbGaD
Propericiazine—Trifluoperazine—HTR6—Alzheimer's disease	0.001	0.0313	CrCbGaD
Propericiazine—Perphenazine—HTR6—Alzheimer's disease	0.00099	0.031	CrCbGaD
Propericiazine—Ethopropazine—BCHE—Alzheimer's disease	0.000975	0.0305	CrCbGaD
Propericiazine—Quetiapine—HTR6—Alzheimer's disease	0.000971	0.0304	CrCbGaD
Propericiazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000871	0.0273	CrCbGaD
Propericiazine—Triflupromazine—BCHE—Alzheimer's disease	0.000798	0.025	CrCbGaD
Propericiazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000785	0.0246	CrCbGaD
Propericiazine—Cyamemazine—HTR2A—Alzheimer's disease	0.00069	0.0216	CrCbGaD
Propericiazine—Mequitazine—CYP2D6—Alzheimer's disease	0.000548	0.0172	CrCbGaD
Propericiazine—Domperidone—CYP2D6—Alzheimer's disease	0.000541	0.0169	CrCbGaD
Propericiazine—Zuclopenthixol—HTR2A—Alzheimer's disease	0.000494	0.0155	CrCbGaD
Propericiazine—Zuclopenthixol—CYP2D6—Alzheimer's disease	0.000452	0.0142	CrCbGaD
Propericiazine—Acepromazine—HTR2A—Alzheimer's disease	0.000443	0.0139	CrCbGaD
Propericiazine—Clomipramine—SLC6A4—Alzheimer's disease	0.000438	0.0137	CrCbGaD
Propericiazine—Thioproperazine—HTR2A—Alzheimer's disease	0.000433	0.0136	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—Alzheimer's disease	0.000426	0.0133	CrCbGaD
Propericiazine—Thiothixene—HTR2A—Alzheimer's disease	0.000426	0.0133	CrCbGaD
Propericiazine—Mesoridazine—HTR2A—Alzheimer's disease	0.000421	0.0132	CrCbGaD
Propericiazine—Thiothixene—CYP2D6—Alzheimer's disease	0.00039	0.0122	CrCbGaD
Propericiazine—Pipotiazine—CYP2D6—Alzheimer's disease	0.00039	0.0122	CrCbGaD
Propericiazine—Chlorpromazine—BCHE—Alzheimer's disease	0.000385	0.0121	CrCbGaD
Propericiazine—Mesoridazine—CYP2D6—Alzheimer's disease	0.000385	0.012	CrCbGaD
Propericiazine—Prochlorperazine—CYP2D6—Alzheimer's disease	0.000372	0.0117	CrCbGaD
Propericiazine—Fluphenazine—HTR2A—Alzheimer's disease	0.000368	0.0115	CrCbGaD
Propericiazine—Propiomazine—HTR2A—Alzheimer's disease	0.000354	0.0111	CrCbGaD
Propericiazine—Clomipramine—HTR2A—Alzheimer's disease	0.000337	0.0105	CrCbGaD
Propericiazine—Fluphenazine—CYP2D6—Alzheimer's disease	0.000337	0.0105	CrCbGaD
Propericiazine—Thioridazine—HTR2A—Alzheimer's disease	0.000317	0.00994	CrCbGaD
Propericiazine—Clomipramine—CYP2D6—Alzheimer's disease	0.000308	0.00965	CrCbGaD
Propericiazine—Methotrimeprazine—HTR2A—Alzheimer's disease	0.000303	0.00949	CrCbGaD
Propericiazine—Promethazine—HTR2A—Alzheimer's disease	0.000298	0.00934	CrCbGaD
Propericiazine—Trifluoperazine—HTR2A—Alzheimer's disease	0.000294	0.00922	CrCbGaD
Propericiazine—Perphenazine—HTR2A—Alzheimer's disease	0.000291	0.00912	CrCbGaD
Propericiazine—Thioridazine—CYP2D6—Alzheimer's disease	0.00029	0.00909	CrCbGaD
Propericiazine—Quetiapine—HTR2A—Alzheimer's disease	0.000286	0.00894	CrCbGaD
Propericiazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	0.000277	0.00868	CrCbGaD
Propericiazine—Promethazine—CYP2D6—Alzheimer's disease	0.000273	0.00855	CrCbGaD
Propericiazine—Perphenazine—CYP2D6—Alzheimer's disease	0.000266	0.00834	CrCbGaD
Propericiazine—Promazine—HTR2A—Alzheimer's disease	0.000263	0.00822	CrCbGaD
Propericiazine—Quetiapine—CYP2D6—Alzheimer's disease	0.000261	0.00818	CrCbGaD
Propericiazine—Chlorpromazine—HTR2A—Alzheimer's disease	0.000231	0.00723	CrCbGaD
Propericiazine—Chlorpromazine—CYP2D6—Alzheimer's disease	0.000211	0.00662	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—APP—Alzheimer's disease	0.0001	0.000994	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CCL2—Alzheimer's disease	9.87e-05	0.00098	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—NPS—Alzheimer's disease	9.79e-05	0.000972	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NPY—Alzheimer's disease	9.72e-05	0.000965	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSENEN—Alzheimer's disease	9.69e-05	0.000962	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IAPP—Alzheimer's disease	9.66e-05	0.000959	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APH1A—Alzheimer's disease	9.55e-05	0.000948	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—A2M—Alzheimer's disease	9.53e-05	0.000946	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PLCB1—Alzheimer's disease	9.45e-05	0.000938	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.4e-05	0.000933	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CRH—Alzheimer's disease	9.38e-05	0.000931	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	9.34e-05	0.000927	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—SST—Alzheimer's disease	9.34e-05	0.000927	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NCSTN—Alzheimer's disease	9.3e-05	0.000923	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PSEN2—Alzheimer's disease	9.23e-05	0.000917	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDK5—Alzheimer's disease	9.14e-05	0.000908	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—F2—Alzheimer's disease	9.14e-05	0.000907	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—APP—Alzheimer's disease	9.1e-05	0.000904	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	9.07e-05	0.000901	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	9.07e-05	0.0009	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CCR5—Alzheimer's disease	8.91e-05	0.000884	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NPS—Alzheimer's disease	8.89e-05	0.000883	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	8.86e-05	0.000879	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	8.86e-05	0.000879	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	8.85e-05	0.000878	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR6—Alzheimer's disease	8.8e-05	0.000874	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLAU—Alzheimer's disease	8.79e-05	0.000873	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.71e-05	0.000865	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—CALM1—Alzheimer's disease	8.7e-05	0.000863	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CHAT—Alzheimer's disease	8.64e-05	0.000858	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TPI1—Alzheimer's disease	8.64e-05	0.000858	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	8.59e-05	0.000853	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—CAV1—Alzheimer's disease	8.58e-05	0.000852	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PRKCG—Alzheimer's disease	8.53e-05	0.000847	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NPY—Alzheimer's disease	8.5e-05	0.000844	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GAB2—Alzheimer's disease	8.48e-05	0.000842	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—SST—Alzheimer's disease	8.48e-05	0.000842	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IAPP—Alzheimer's disease	8.44e-05	0.000838	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	8.33e-05	0.000827	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MAOB—Alzheimer's disease	8.29e-05	0.000823	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—APP—Alzheimer's disease	8.27e-05	0.000821	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CRH—Alzheimer's disease	8.2e-05	0.000814	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—F2—Alzheimer's disease	8.17e-05	0.000811	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CCL2—Alzheimer's disease	8.14e-05	0.000809	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCR5—Alzheimer's disease	8.09e-05	0.000803	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS2—Alzheimer's disease	8.07e-05	0.000802	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSENEN—Alzheimer's disease	7.99e-05	0.000794	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	7.98e-05	0.000792	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2A—Alzheimer's disease	7.91e-05	0.000786	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	7.88e-05	0.000782	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	7.81e-05	0.000775	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	7.8e-05	0.000774	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	7.77e-05	0.000772	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NPS—Alzheimer's disease	7.77e-05	0.000771	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PPP3CA—Alzheimer's disease	7.73e-05	0.000768	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—A2M—Alzheimer's disease	7.71e-05	0.000765	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.7e-05	0.000764	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	7.67e-05	0.000762	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—F2—Alzheimer's disease	7.64e-05	0.000759	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTK2B—Alzheimer's disease	7.62e-05	0.000757	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	7.56e-05	0.000751	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	7.48e-05	0.000743	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NTRK2—Alzheimer's disease	7.41e-05	0.000736	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GAB2—Alzheimer's disease	7.41e-05	0.000736	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SST—Alzheimer's disease	7.41e-05	0.000736	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CALM1—Alzheimer's disease	7.38e-05	0.000733	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GSK3A—Alzheimer's disease	7.35e-05	0.00073	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	7.31e-05	0.000726	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	7.31e-05	0.000726	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	7.29e-05	0.000724	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APP—Alzheimer's disease	7.22e-05	0.000717	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	7.16e-05	0.000711	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.14e-05	0.000709	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	6.99e-05	0.000694	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	6.96e-05	0.000691	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—F2—Alzheimer's disease	6.94e-05	0.000689	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	6.92e-05	0.000687	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PLCB1—Alzheimer's disease	6.82e-05	0.000677	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	6.71e-05	0.000666	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ACHE—Alzheimer's disease	6.7e-05	0.000665	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	6.63e-05	0.000658	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	6.62e-05	0.000657	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	6.49e-05	0.000644	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.48e-05	0.000643	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	6.44e-05	0.00064	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	6.36e-05	0.000632	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NGFR—Alzheimer's disease	6.36e-05	0.000631	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.35e-05	0.000631	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	6.33e-05	0.000629	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CREB1—Alzheimer's disease	6.32e-05	0.000627	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ENO1—Alzheimer's disease	6.28e-05	0.000624	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	6.28e-05	0.000624	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	6.26e-05	0.000621	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	6.24e-05	0.00062	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	6.24e-05	0.000619	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADAM10—Alzheimer's disease	6.21e-05	0.000617	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CCL2—Alzheimer's disease	6.18e-05	0.000614	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	6.16e-05	0.000612	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	6.07e-05	0.000603	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	6.07e-05	0.000603	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	6.07e-05	0.000603	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	6.05e-05	0.0006	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	6.02e-05	0.000598	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	6.02e-05	0.000597	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	5.92e-05	0.000587	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.89e-05	0.000585	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—S100B—Alzheimer's disease	5.87e-05	0.000583	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—BCHE—Alzheimer's disease	5.84e-05	0.00058	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	5.79e-05	0.000575	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	5.77e-05	0.000573	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	5.74e-05	0.00057	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	5.71e-05	0.000567	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	5.68e-05	0.000564	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF2—Alzheimer's disease	5.59e-05	0.000555	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	5.58e-05	0.000554	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	5.54e-05	0.00055	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	5.51e-05	0.000547	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	5.47e-05	0.000543	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1R—Alzheimer's disease	5.41e-05	0.000537	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	5.35e-05	0.000531	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	5.34e-05	0.00053	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	5.25e-05	0.000521	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	5.23e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	5.21e-05	0.000517	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LPL—Alzheimer's disease	5.19e-05	0.000515	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	5.18e-05	0.000514	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	5.16e-05	0.000513	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	5.15e-05	0.000511	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MEF2C—Alzheimer's disease	5.14e-05	0.00051	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	5.09e-05	0.000505	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	5.06e-05	0.000503	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCG—Alzheimer's disease	5.04e-05	0.000501	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	5.01e-05	0.000497	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	5.01e-05	0.000497	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	5.01e-05	0.000497	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	4.99e-05	0.000495	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	4.97e-05	0.000493	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NGF—Alzheimer's disease	4.91e-05	0.000488	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	4.88e-05	0.000485	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	4.81e-05	0.000478	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCR5—Alzheimer's disease	4.78e-05	0.000474	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	4.69e-05	0.000466	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	4.68e-05	0.000464	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—Alzheimer's disease	4.67e-05	0.000464	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	4.61e-05	0.000457	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	4.6e-05	0.000457	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	4.58e-05	0.000455	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	4.58e-05	0.000455	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	4.43e-05	0.00044	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	4.36e-05	0.000433	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—Alzheimer's disease	4.35e-05	0.000431	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—Alzheimer's disease	4.35e-05	0.000431	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	4.31e-05	0.000428	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	4.3e-05	0.000427	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	4.29e-05	0.000426	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	4.27e-05	0.000424	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	4.25e-05	0.000422	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	4.21e-05	0.000418	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	4.2e-05	0.000417	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LPL—Alzheimer's disease	4.19e-05	0.000416	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	4.18e-05	0.000415	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	4.15e-05	0.000412	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	4.13e-05	0.00041	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—F2—Alzheimer's disease	4.1e-05	0.000407	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	4.02e-05	0.000399	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.01e-05	0.000398	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	3.97e-05	0.000394	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	3.91e-05	0.000388	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	3.83e-05	0.00038	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	3.78e-05	0.000375	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	3.77e-05	0.000375	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	3.76e-05	0.000374	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	3.73e-05	0.000371	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—Alzheimer's disease	3.71e-05	0.000369	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	3.66e-05	0.000363	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	3.65e-05	0.000363	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	3.59e-05	0.000357	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	3.57e-05	0.000355	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	3.56e-05	0.000353	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	3.56e-05	0.000353	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	3.53e-05	0.000351	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	3.53e-05	0.00035	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	3.53e-05	0.00035	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—Alzheimer's disease	3.51e-05	0.000349	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	3.5e-05	0.000348	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	3.48e-05	0.000346	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	3.47e-05	0.000345	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	3.41e-05	0.000338	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	3.4e-05	0.000337	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	3.36e-05	0.000333	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	3.32e-05	0.00033	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.28e-05	0.000326	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	3.26e-05	0.000323	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.23e-05	0.000321	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.16e-05	0.000314	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	3.08e-05	0.000306	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.06e-05	0.000304	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	3.06e-05	0.000304	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	3.04e-05	0.000302	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—Alzheimer's disease	3e-05	0.000298	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	2.99e-05	0.000297	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.98e-05	0.000296	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.95e-05	0.000293	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	2.94e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.94e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.94e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.91e-05	0.000289	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.8e-05	0.000278	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.79e-05	0.000277	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.77e-05	0.000275	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.76e-05	0.000274	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.75e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.71e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.67e-05	0.000265	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.63e-05	0.000261	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.54e-05	0.000253	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.54e-05	0.000252	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.53e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.52e-05	0.000251	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.51e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.47e-05	0.000245	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.43e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.41e-05	0.000239	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.35e-05	0.000233	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.28e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.26e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.25e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.2e-05	0.000218	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.15e-05	0.000214	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.08e-05	0.000207	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.07e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.92e-05	0.000191	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.89e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.87e-05	0.000185	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.86e-05	0.000184	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.77e-05	0.000176	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.76e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.72e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.71e-05	0.00017	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.62e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-05	0.000157	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.45e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.33e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.21e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.2e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.1e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.01e-05	0.0001	CbGpPWpGaD
